森萱医药
(920946)
| 流通市值：46.05亿 | | | 总市值：46.06亿 |
| 流通股本：4.27亿 | | | 总股本：4.27亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 479,118,465.9 | 458,624,592.8 | 537,868,689.73 | 583,318,157.66 |
| 交易性金融资产 | 154,637,921.11 | 133,558,084.28 | 137,550,364.69 | 55,078,493.05 |
| 应收票据及应收账款 | 81,056,317.36 | 65,653,787.04 | 60,695,494.42 | 72,149,925.79 |
| 其中：应收票据 | 14,275,589.12 | 11,833,606.52 | 10,373,736.88 | 13,297,961.71 |
| 应收账款 | 66,780,728.24 | 53,820,180.52 | 50,321,757.54 | 58,851,964.08 |
| 应收款项融资 | 34,512,941.25 | 25,490,716.17 | 28,760,907.04 | 28,537,550.48 |
| 预付款项 | 3,712,758.77 | 5,008,135.09 | 5,707,783.24 | 2,750,262.07 |
| 其他应收款合计 | 127,670.97 | 169,677.78 | 184,931.66 | 203,001.93 |
| 存货 | 112,279,118.16 | 124,072,283.11 | 119,135,520.81 | 120,847,737.8 |
| 其他流动资产 | 118,508.34 | 211,929.04 | 143,263.72 | 135,165.75 |
| 流动资产合计 | 865,563,701.86 | 812,789,205.31 | 890,046,955.31 | 863,020,294.53 |
| 非流动资产: | | | | |
| 固定资产 | 307,534,150.11 | 317,895,384.65 | 329,161,523.78 | 312,441,232.37 |
| 在建工程 | 2,125,851.49 | 1,087,597.14 | 997,169.82 | 24,256,837.56 |
| 使用权资产 | 934,976.83 | 614,001.72 | 1,021,980.27 | 1,412,859.13 |
| 无形资产 | 34,747,926.22 | 35,038,016.6 | 35,328,106.99 | 35,620,177.57 |
| 递延所得税资产 | 5,802,954.43 | 5,288,553.49 | 5,351,690.22 | 5,317,521.94 |
| 其他非流动资产 | 185,705,115.37 | 184,641,394.22 | 112,786,630.14 | 112,088,821.92 |
| 非流动资产合计 | 536,850,974.45 | 544,564,947.82 | 484,647,101.22 | 491,137,450.49 |
| 资产总计 | 1,402,414,676.31 | 1,357,354,153.13 | 1,374,694,056.53 | 1,354,157,745.02 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 32,202,165.5 | 32,127,499.98 | 30,897,076.1 | 30,898,316.4 |
| 应付账款 | 32,202,165.5 | 32,127,499.98 | 30,897,076.1 | 30,898,316.4 |
| 合同负债 | 4,129,386.98 | 5,807,750.41 | 4,970,695.32 | 4,565,786.52 |
| 应付职工薪酬 | 20,506,898.93 | 16,903,276.85 | 15,548,097 | 23,457,068.06 |
| 应交税费 | 9,769,520.23 | 9,517,121.81 | 8,953,807.9 | 10,660,394.92 |
| 其他应付款合计 | 6,340,535.86 | 5,110,076.38 | 5,183,864.01 | 6,105,517.66 |
| 一年内到期的非流动负债 | 143,674.88 | 12,753.83 | 999,416.31 | 1,237,109.83 |
| 其他流动负债 | 8,760,832.34 | 7,578,023.41 | 5,845,037.49 | 6,866,083.47 |
| 流动负债合计 | 81,853,014.72 | 77,056,502.67 | 72,397,994.13 | 83,790,276.86 |
| 非流动负债: | | | | |
| 租赁负债 | 472,413.06 | - | - | - |
| 递延收益 | 2,161,810.05 | 2,215,815.87 | 2,269,821.69 | 2,323,827.51 |
| 递延所得税负债 | 3,684,657.35 | 3,233,913.11 | 3,238,250.02 | 3,126,040.74 |
| 非流动负债合计 | 6,318,880.46 | 5,449,728.98 | 5,508,071.71 | 5,449,868.25 |
| 负债合计 | 88,171,895.18 | 82,506,231.65 | 77,906,065.84 | 89,240,145.11 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 426,918,340 | 426,918,340 | 426,918,340 | 426,918,340 |
| 资本公积 | 218,259,925.93 | 217,839,394.18 | 217,559,039.68 | 217,559,039.68 |
| 专项储备 | 4,575,058.11 | 3,743,730.19 | 2,842,363.3 | 1,420,641 |
| 盈余公积 | 49,089,945.29 | 49,089,945.29 | 49,089,945.29 | 49,089,945.29 |
| 未分配利润 | 540,264,673.34 | 504,528,696.38 | 525,409,670.55 | 496,377,191.59 |
| 归属于母公司股东权益合计 | 1,239,107,942.67 | 1,202,120,106.04 | 1,221,819,358.82 | 1,191,365,157.56 |
| 少数股东权益 | 75,134,838.46 | 72,727,815.44 | 74,968,631.87 | 73,552,442.35 |
| 股东权益合计 | 1,314,242,781.13 | 1,274,847,921.48 | 1,296,787,990.69 | 1,264,917,599.91 |
| 负债和股东权益合计 | 1,402,414,676.31 | 1,357,354,153.13 | 1,374,694,056.53 | 1,354,157,745.02 |
| 公告日期 | 2025-10-29 | 2025-08-29 | 2025-04-29 | 2025-04-14 |
| 审计意见(境内) | | | | 标准无保留意见 |